Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SI-BONE, Inc.SIBN · Entity 2501 | Chief Op & Financial Officer | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SI-BONE, Inc.
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 221,724 |
Reported balance
After 2026-10-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 1,560 · Balance 221,724 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 219,966 |
Reported balance
After 2026-10-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-10-02 · Sale · Disposed 1,758 · Balance 219,966 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 218,235 |
Reported balance
After 2026-10-05 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-10-05 · Sale · Disposed 1,731 · Balance 218,235 F3: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. F4: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025.
F4: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2025 Filed Apr 4, 2025 21:12 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,754 | $14.14 | $24,793.14 |
DisclosureSEC source: 0001562180-25-003005 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,293 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $13.78 USD to $14.37 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 180,329 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 21:12 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,557 | $14.09 | $21,930.35 |
DisclosureSEC source: 0001562180-25-003005 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,047 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.78 USD to $14.32 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:18 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,167 | $16.74 | $19,530.45 |
DisclosureSEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 7 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,604 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F7 · price: This transaction was executed in multiple trades at prices ranging from $16.21 USD to $16.94 USD; the price reported above reflects the weighted average sale price. F8 · balance_after: Includes 187,109 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:18 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 524 | $17.35 | $9,089.09 |
DisclosureSEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 6 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,771 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.29 USD to $17.40 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:18 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,782 | $16.94 | $64,070.86 |
DisclosureSEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 5 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,295 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F6 · price: This transaction was executed in multiple trades at prices ranging from $16.285 USD to $17.28 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:18 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,971 | $16.86 | $50,085.71 |
DisclosureSEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 4 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,077 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $16.285 USD to $17.26 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:18 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,276 | $16.66 | $21,254.97 |
DisclosureSEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,048 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $16.17 USD to $16.93 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:18 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 156 | $17.36 | $2,708.38 |
DisclosureSEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,324 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.29 USD to $17.40 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:18 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,304 | $16.70 | $21,778.76 |
DisclosureSEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,480 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.22 USD to $16.92 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:09 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 23,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000980 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,784 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. F3 · balance_after: Includes 210,079 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:09 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 71,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000980 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,918 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on February 15, 2025, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 23:56 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,726 | $13.91 | $24,007.45 |
DisclosureSEC source: 0001562180-25-000214 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,319 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $13.65 USD to $14.36 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Includes 114,614 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 23:56 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,944 | $13.93 | $27,085.75 |
DisclosureSEC source: 0001562180-25-000214 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,045 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $13.66 USD to $14.32 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 23:56 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,634 | $13.90 | $22,708.84 |
DisclosureSEC source: 0001562180-25-000214 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,989 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.66 USD to $14.355 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 22:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,274 | $12.67 | $16,138.65 |
DisclosureSEC source: 0001562180-24-007839 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,623 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $12.41 USD to $13.025 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 124,413 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 22:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,165 | $12.70 | $14,797.95 |
DisclosureSEC source: 0001562180-24-007839 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,897 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.43 USD to $13.04 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 22:54 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,751 | $13.59 | $23,795.74 |
DisclosureSEC source: 0001562180-24-007249 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,062 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.70 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 129,416 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 22:54 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,554 | $13.57 | $21,090.58 |
DisclosureSEC source: 0001562180-24-007249 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,813 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.70 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 21:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,414 | $16.35 | $23,118.90 |
DisclosureSEC source: 0001562180-24-006636 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,367 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · balance_after: Includes 136,197 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 21:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006636 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,781 F1 · kind: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest on January 1, 2025, subject to the Reporting Person's continued service through the relevant vesting date. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 23:53 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,155 | $13.88 | $16,033.25 |
DisclosureSEC source: 0001562180-24-006414 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,762 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $13.77 USD to $14.15 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F4 · balance_after: Includes 133,178 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 23:53 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,263 | $13.86 | $17,504.42 |
DisclosureSEC source: 0001562180-24-006414 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,917 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.77 USD to $14.13 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 21:41 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,753 | $12.91 | $22,625.45 |
DisclosureSEC source: 0001562180-24-005631 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,180 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $12.725 USD to $12.98 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 138,180 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 21:41 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,556 | $12.90 | $20,068.20 |
DisclosureSEC source: 0001562180-24-005631 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,933 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.77 USD to $13.00 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2024 Filed May 18, 2024 00:06 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,166 | $15.14 | $17,648.23 |
DisclosureSEC source: 0001562180-24-004173 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,489 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.05 USD to $15.21 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Included 1,414 shares acquired under the SI-BONE Employee Stock Purchase Plan on May 15, 2024. F4 · balance_after: Includes 144,960 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 18, 2024 00:06 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,275 | $15.14 | $19,305.67 |
DisclosureSEC source: 0001562180-24-004173 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,241 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.05 USD to $15.21 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 23:59 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,285 | $15.46 | $19,866.49 |
DisclosureSEC source: 0001562180-24-003311 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,516 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $15.37 USD to $15.57 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 149,963 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 23:59 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,140 | $15.45 | $17,607.30 |
DisclosureSEC source: 0001562180-24-003311 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,801 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.39 USD to $15.51 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,282 | $20.96 | $47,819.31 |
DisclosureSEC source: 0001562180-24-001536 · primarydocument.xml · nonDerivative · entry 4 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,941 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 156,743 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,266 | $20.96 | $68,439.03 |
DisclosureSEC source: 0001562180-24-001536 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,223 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 934 | $20.96 | $19,571.97 |
DisclosureSEC source: 0001562180-24-001536 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,489 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 854 | $20.96 | $17,895.57 |
DisclosureSEC source: 0001562180-24-001536 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,423 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:52 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 17,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000311 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,277 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. F3 · balance_after: Includes 177,420 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:52 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 51,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000311 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,275 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on January 1, 2024, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:06 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,470 | $20.92 | $30,758.28 |
DisclosureSEC source: 0001562180-24-000267 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,268 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.63 USD to $21.24 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 109,411 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 828 | $17.54 | $14,525.69 |
DisclosureSEC source: 0001562180-23-007804 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,738 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.16 USD to $17.88 USD; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 113,004 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 905 | $17.63 | $15,951.98 |
DisclosureSEC source: 0001562180-23-007804 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,566 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.16 USD to $17.88 USD; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,244 | $21.15 | $26,309.85 |
DisclosureSEC source: 0001562180-23-007212 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,471 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.93 USD to $21.29 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 118,006 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 20:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 905 | $20.94 | $18,948.62 |
DisclosureSEC source: 0001562180-23-006436 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,715 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $20.75 USD to $21.13 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 121,598 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 20:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 828 | $21.03 | $17,414.41 |
DisclosureSEC source: 0001562180-23-006436 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,620 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.82 USD to $21.125 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 22:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,244 | $26.70 | $33,218.78 |
DisclosureSEC source: 0001562180-23-005729 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,448 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.62 USD to $26.93 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 126,601 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,272 | $28.00 | $91,616.00 |
DisclosureSEC source: 0001562180-23-005038 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,692 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 130,194 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| May 16, 2023 Filed May 18, 2023 21:34 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,891 | $24.39 | $46,123.00 |
DisclosureSEC source: 0001562180-23-004249 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,964 F4 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F5 · balance_after: Included 1,891 shares acquired under the SI-BONE Employee Stock Purchase Plan on May 15, 2023. F6 · balance_after: Includes 130,194 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer'scommon stock Read SEC document |
| May 16, 2023 Filed May 18, 2023 21:34 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 828 | $24.46 | $20,250.06 |
DisclosureSEC source: 0001562180-23-004249 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,964 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $24.02 USD to $24.78 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2023 Filed May 18, 2023 21:34 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 905 | $24.68 | $22,332.32 |
DisclosureSEC source: 0001562180-23-004249 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 158,792 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.14 USD to $24.83 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 22:46 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,229 | $19.30 | $23,719.09 |
DisclosureSEC source: 0001562180-23-003454 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,697 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.15 to $19.53; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 135,196 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:44 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,986 | $21.00 | $41,706.00 |
DisclosureSEC source: 0001562180-23-002188 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,926 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 138,788 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer'scommon stock. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,546 | $16.78 | $25,948.84 |
DisclosureSEC source: 0001562180-23-001492 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,912 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 138,788 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 870 | $16.80 | $14,615.39 |
DisclosureSEC source: 0001562180-23-001492 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,458 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 796 | $16.93 | $13,474.37 |
DisclosureSEC source: 0001562180-23-001492 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,328 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.